ArticlePLoS medicine2025

Reduced insulin use and diabetes complications upon introduction of SGLT-2 inhibitors and GLP1-receptor agonists in low- and middle-income countries: A microsimulation.

Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC)PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.